PCL-based nanoparticles for doxorubicin-ezetimibe co-delivery: A combination therapy for prostate cancer using a drug repurposing strategy
Article in Bioimpacts (January 2023)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Bioimpacts (January 2023)
Article in Frontiers in Aging (December 2022)
Article in Journal of Clinical Medicine (March 2022)